Active enhancement of tissue allografts with antilymphocyte serum and bone marrow.
D000328:Adult; D000818:Animals; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D001853:Bone Marrow / Q000276:immunology*; D001854:Bone Marrow Cells; D002102:Cadaver; D002678:Chimera; D004285:Dogs; D005260:Female; D006084:Graft Rejection / Q000517:prevention & control*; D006087:Graft vs Host Reaction / Q000276:immunology; D006801:Humans; D007108:Immune Tolerance; D007111:Immunity, Cellular; D007165:Immunosuppression Therapy / Q000379:methods; D016030:Kidney Transplantation; D008221:Lymphoid Tissue / Q000276:immunology; D051379:Mice; D008815:Mice, Inbred Strains / Q000276:immunology; D016038:Skin Transplantation; D013154:Spleen / Q000276:immunology; D013934:Thymectomy; D013997:Time Factors; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum